References
- Alten R, et al. Rheumatol Ther. 2026;13(1):231-242.
- Olumiant® Summary of Product Characteristics, March 2024.
- Taylor PC, et al. Ann Rheum Dis. 2022;81(3):335-343.
- Okamoto N, et al. Mod Rheumatol. 2025;35(2):215-224.
- Bieber T, et al. Adv Ther. 2022;39(11):4910-4960.
CMAT-39396 | Privacy Policy | PI Information for Olumiant®
This information is intended for Health Care Professionals only.
This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly’s prior permission.
Lilly and Olumiant® are registered trademarks of Eli Lilly and Company.
© 2026 Eli Lilly and Company. All Rights Reserved.
